Stocks
Atossa Therapeutics, Inc.ATOS
NASDAQHealthcareBiotechnology$5.01-0.79%
Price as of · delayed, not real-time
Focused on developing innovative therapeutics for breast cancer and other breast conditions, this biopharmaceutical company has garnered investor attention for its pipeline of proprietary drug candidates. Its clinical-stage programs target unmet medical needs, making it a speculative yet closely watched player in the oncology space.
Market Cap: $43.1M52W Range: $3.76 – $19.35
Congressional Interest in Atossa Therapeutics, Inc. (ATOS)
1 member of Congress has disclosed 1 trade in Atossa Therapeutics, Inc. (ATOS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading ATOS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-25 | Roger W. Marshall | buy | $1K – $15K |